Orbimed Advisors LLC Aurinia Pharmaceuticals Inc. Transaction History

Orbimed Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $66.3 Million - $143 Million	-6,069,032 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $16.2 Million - $24.6 Million	1,315,032 Added 27.66%	6,069,032 $78.8 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $46.9 Million - $59.3 Million	3,557,653 Added 297.38%	4,754,000 $70 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $1.98 Million - $2.57 Million	-140,200 Reduced 10.49%	1,196,347 $19.4 Million
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $11.4 Million - $21.7 Million	-1,008,900 Reduced 43.02%	1,336,547 $19.4 Million
Q4 2019 Feb 14, 2020	SELL	$3.88 - $21.42 $4.6 Million - $25.4 Million	-1,185,555 Reduced 33.58%	2,345,447 $47.5 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $6.75 $2.31 Million - $2.57 Million	381,192 Added 12.1%	3,531,002 $23.2 Million
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $19.1 Million - $24.1 Million	3,149,810 New	3,149,810 $20.5 Million
Q3 2018 Nov 14, 2018	SELL	$5.27 - $6.64 $882,298 - $1.11 Million	-167,419 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.36 $2.32 Million - $2.92 Million	-458,856 Reduced 73.27%	167,419 $943,000
Q1 2018 May 15, 2018	SELL	$4.85 - $5.99 $5.68 Million - $7.02 Million	-1,171,125 Reduced 65.16%	626,275 $3.25 Million
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $10.3 Million - $12.4 Million	1,797,400	1,797,400 $11.3 Million

207

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.28B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.